TRAPHAGEN INVESTMENT ADVISORS LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRAPHAGEN INVESTMENT ADVISORS LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$299,507
-45.9%
37,345
+0.0%
0.03%
-44.1%
Q1 2024$553,438
+86.1%
37,344
+2.1%
0.06%
+68.6%
Q4 2023$297,347
+81.6%
36,574
+1.6%
0.04%
+66.7%
Q3 2023$163,782
-34.3%
35,996
+1.6%
0.02%
-34.4%
Q2 2023$249,392
+13.3%
35,425
-1.7%
0.03%0.0%
Q1 2023$220,137
+15.1%
36,029
+20.4%
0.03%
+6.7%
Q4 2022$191,291
+35.2%
29,936
+102.7%
0.03%
+15.4%
Q3 2022$141,458
-42.3%
14,766
-33.5%
0.03%
-42.2%
Q2 2022$245,187
-53.9%
22,209
+106.2%
0.04%
-47.7%
Q1 2022$531,558
-3.2%
10,769
+0.1%
0.09%
-4.4%
Q4 2021$549,400
-1.1%
10,762
+0.2%
0.09%
-10.0%
Q3 2021$555,250
-0.2%
10,744
+0.1%
0.10%
+5.3%
Q2 2021$556,291
-6.5%
10,733
-6.6%
0.10%
-12.8%
Q1 2021$594,849
-12.9%
11,488
-12.1%
0.11%
-11.4%
Q4 2020$682,568
-3.3%
13,071
-3.4%
0.12%
-14.0%
Q3 2020$705,54813,5370.14%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders